Literature DB >> 30598249

Medical therapy for atherosclerotic cardiovascular disease in patients with myocardial injury after non-cardiac surgery.

Jin F Chen1, Nathaniel R Smilowitz2, Jung T Kim3, Germaine Cuff3, Alina Boltunova4, Jason Toffey5, Jeffrey S Berger6, Andrew Rosenberg3, Samir Kendale3.   

Abstract

BACKGROUND: Myocardial injury after non-cardiac surgery (MINS) is a common post-operative cardiovascular complication and is associated with short and long-term mortality. The objective of this study was to describe the contemporary management of patients with and without MINS after total joint and spine orthopedic surgery at a large urban health system in the United States.
METHODS: Adults admitted for total joint and major spine surgery from January 2013 through December 2015 with ≥1 cardiac troponin (cTn) measurement during their hospitalization were identified. MINS was defined by a peak cTn above the 99th percentile of the upper reference limit. Demographics, medical comorbidities, and admission and discharge medications were reviewed for all patients.
RESULTS: A total of 2561 patients underwent 2798 orthopedic surgeries, and 236 cases of MINS were identified. Patients with MINS were older (71.9 ± 10.9 vs. 67.0 ± 10.0, p < 0.001) and more likely to have cardiovascular risk factors, including hypertension, chronic kidney disease, prior stroke, coronary artery disease, prior MI, and a history of heart failure. Among patients with MINS, only 112 (47.5%) were discharged on a combination of aspirin and statin. Patients with MINS were more likely to be prescribed a statin (154 [65.3%] vs. 1463 [57.1%], p = 0.018), beta-blocker (147 [62.3%] vs. 1194 [46.6%], p < 0.001), and oral anticoagulation (65 [27.5%] vs. 436 [17.0%], p < 0.001) than patients without MINS.
CONCLUSIONS: The proportion of patients with MINS who were prescribed medical therapy for atherosclerotic cardiovascular disease was low. Additional efforts to determine optimal management of MINS are warranted. Published by Elsevier B.V.

Entities:  

Keywords:  Medical therapy; Myocardial infarction; Myocardial injury after noncardiac surgery; Perioperative; Surgery; Troponin

Mesh:

Year:  2018        PMID: 30598249      PMCID: PMC6358460          DOI: 10.1016/j.ijcard.2018.12.032

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  29 in total

1.  AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association.

Authors:  Sidney C Smith; Emelia J Benjamin; Robert O Bonow; Lynne T Braun; Mark A Creager; Barry A Franklin; Raymond J Gibbons; Scott M Grundy; Loren F Hiratzka; Daniel W Jones; Donald M Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D Peterson; Ralph L Sacco; John Spertus; James H Stein; Kathryn A Taubert
Journal:  J Am Coll Cardiol       Date:  2011-11-03       Impact factor: 24.094

Review 2.  Perioperative myocardial infarction.

Authors:  Giora Landesberg; W Scott Beattie; Morris Mosseri; Allan S Jaffe; Joseph S Alpert
Journal:  Circulation       Date:  2009-06-09       Impact factor: 29.690

3.  2011 ACCF/AHA focused update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (updating the 2007 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.

Authors:  R Scott Wright; Jeffrey L Anderson; Cynthia D Adams; Charles R Bridges; Donald E Casey; Steven M Ettinger; Francis M Fesmire; Theodore G Ganiats; Hani Jneid; A Michael Lincoff; Eric D Peterson; George J Philippides; Pierre Theroux; Nanette K Wenger; James Patrick Zidar; Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette K Wenger; R Scott Wright
Journal:  J Am Coll Cardiol       Date:  2011-03-28       Impact factor: 24.094

4.  Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery.

Authors:  P J Devereaux; Matthew T V Chan; Pablo Alonso-Coello; Michael Walsh; Otavio Berwanger; Juan Carlos Villar; C Y Wang; R Ignacio Garutti; Michael J Jacka; Alben Sigamani; Sadeesh Srinathan; Bruce M Biccard; Clara K Chow; Valsa Abraham; Maria Tiboni; Shirley Pettit; Wojciech Szczeklik; Giovanna Lurati Buse; Fernando Botto; Gordon Guyatt; Diane Heels-Ansdell; Daniel I Sessler; Kristian Thorlund; Amit X Garg; Marko Mrkobrada; Sabu Thomas; Reitze N Rodseth; Rupert M Pearse; Lehana Thabane; Matthew J McQueen; Tomas VanHelder; Mohit Bhandari; Jackie Bosch; Andrea Kurz; Carisi Polanczyk; German Malaga; Peter Nagele; Yannick Le Manach; Martin Leuwer; Salim Yusuf
Journal:  JAMA       Date:  2012-06-06       Impact factor: 56.272

5.  Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study.

Authors:  P J Devereaux; Denis Xavier; Janice Pogue; Gordon Guyatt; Alben Sigamani; Ignacio Garutti; Kate Leslie; Purnima Rao-Melacini; Sue Chrolavicius; Homer Yang; Colin Macdonald; Alvaro Avezum; Luc Lanthier; Weijiang Hu; Salim Yusuf
Journal:  Ann Intern Med       Date:  2011-04-19       Impact factor: 25.391

6.  Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial.

Authors:  Anai E S Durazzo; Fábio S Machado; Dimas T Ikeoka; Cláudia De Bernoche; Maristela C Monachini; Pedro Puech-Leão; Bruno Caramelli
Journal:  J Vasc Surg       Date:  2004-05       Impact factor: 4.268

7.  Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery.

Authors:  Peter K Lindenauer; Penelope Pekow; Kaijun Wang; Benjamin Gutierrez; Evan M Benjamin
Journal:  JAMA       Date:  2004-05-05       Impact factor: 56.272

8.  Myocardial injury after noncardiac surgery and its association with short-term mortality.

Authors:  Judith A R van Waes; Hendrik M Nathoe; Jurgen C de Graaff; Hans Kemperman; Gert Jan de Borst; Linda M Peelen; Wilton A van Klei
Journal:  Circulation       Date:  2013-05-10       Impact factor: 29.690

9.  Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.

Authors:  Edward J Mills; Beth Rachlis; Ping Wu; Philip J Devereaux; Paul Arora; Dan Perri
Journal:  J Am Coll Cardiol       Date:  2008-11-25       Impact factor: 24.094

Review 10.  Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery.

Authors:  Robert D Sanders; Amanda Nicholson; Sharon R Lewis; Andrew F Smith; Phil Alderson
Journal:  Cochrane Database Syst Rev       Date:  2013-07-03
View more
  2 in total

1.  Myocardial Injury After Noncardiac Surgery: A Systematic Review and Meta-Analysis.

Authors:  Nathaniel R Smilowitz; Gabriel Redel-Traub; Anais Hausvater; Andrew Armanious; Joseph Nicholson; Christian Puelacher; Jeffrey S Berger
Journal:  Cardiol Rev       Date:  2019 Nov/Dec       Impact factor: 2.644

2.  Characteristics and long-term mortality of patients with ST-elevation or non-ST-elevation myocardial infarction after orthopaedic surgery.

Authors:  Wenlan Hu; Kaiping Zhao; Youzhou Chen; Jihong Wang; Mei Zheng; Ying Zhao; Qiong Zhao; Xingshan Zhao
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.